MedPath

UNIVERSITY OF CALIFORNIA, DAVIS

UNIVERSITY OF CALIFORNIA, DAVIS logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1905-01-01
Employees
10K
Market Cap
-
Website
http://www.ucdavis.edu

Clinical Trials

757

Active:36
Completed:486

Trial Phases

6 Phases

Early Phase 1:21
Phase 1:72
Phase 2:46
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (625 trials with phase data)• Click on a phase to view related trials

Not Applicable
439 (70.2%)
Phase 1
72 (11.5%)
Phase 2
46 (7.4%)
Phase 4
35 (5.6%)
Early Phase 1
21 (3.4%)
Phase 3
12 (1.9%)

Effect of Semiconductor Embedded Wearable Sleeve on Treatment of Primary Dysmenorrhea Symptoms

Not Applicable
Not yet recruiting
Conditions
Primary Dysmenorrhea
Primary Dysmenorrhea (PD)
Menstrual Cramps
Women's Health
First Posted Date
2025-09-16
Last Posted Date
2025-09-16
Lead Sponsor
University of California, Davis
Target Recruit Count
100
Registration Number
NCT07176780

Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes

Not yet recruiting
Conditions
Gestational Diabetes Mellitus (GDM)
Diabetes Type 2
Breastfeeding Continuation
Breastfeeding Support
First Posted Date
2025-09-16
Last Posted Date
2025-09-16
Lead Sponsor
University of California, Davis
Target Recruit Count
10
Registration Number
NCT07176793

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

Not Applicable
Not yet recruiting
Conditions
Glioblastoma
Interventions
Procedure: Laser interstitial thermal therapy
First Posted Date
2025-08-28
Last Posted Date
2025-08-28
Lead Sponsor
University of California, Davis
Target Recruit Count
20
Registration Number
NCT07145112
Locations
🇺🇸

University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

Mango Intake and Gut and Cardiometabolic Health in Hispanic/Latino Adolescents

Not Applicable
Not yet recruiting
Conditions
Cardiometabolic Health Indicators
Vascular Function in Healthy Volunteers
Inflammation
First Posted Date
2025-08-15
Last Posted Date
2025-08-15
Lead Sponsor
University of California, Davis
Target Recruit Count
25
Registration Number
NCT07125001

Using an AI Mobile Application to Promote Healthy Eating

Not Applicable
Not yet recruiting
Conditions
Healthy
First Posted Date
2025-08-07
Last Posted Date
2025-08-07
Lead Sponsor
University of California, Davis
Target Recruit Count
114
Registration Number
NCT07108452
Locations
🇺🇸

University of California, Davis - Department of Nutrition, Davis, California, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 152
  • Next

News

UC Davis Scientists Develop Non-Hallucinogenic LSD Derivative That Shows Promise for Schizophrenia Treatment

Researchers at UC Davis created JRT, a novel compound derived from LSD by repositioning just two atoms in its molecular structure, potentially offering a breakthrough treatment for schizophrenia without hallucinogenic effects.

Promising Alzheimer's Vaccine Targeting Tau Protein Advances Toward Human Trials

University of New Mexico researchers have developed a vaccine that generates antibodies against pathological tau protein (pT181), showing efficacy in both mice and non-human primates with strong immune responses.

CRISPR-Cas9 Reduces VEGF Levels in Monkeys, Shows Retinal Toxicity at High Doses

CRISPR-Cas9 targeting VEGFA delivered via AAV vectors reduces VEGF levels in monkeys, potentially treating choroidal neovascularisation (CNV).

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.